TTK Healthcare (BOM:507747) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


BOM:507747 TTK Healthcare Ltd BOM:507747
76 GF Score
Price ₹921.35
GF Value ₹1,453.45
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is TTK Healthcare Cash Flow for Dividends?

TTK Healthcare BOM:507747 76 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:507747 with a GF Score™ of 76/100 and a GF Value™ of ₹1,453.45 (Significantly Undervalued). The stock has 1 warning sign investors should review.

TTK Healthcare's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

TTK Healthcare's annual payment of dividends stayed the same from Mar. 2024 (₹-141 Mil) to Mar. 2025 (₹-141 Mil) and stayed the same from Mar. 2025 (₹-141 Mil) to Mar. 2026 (₹-141 Mil).

TTK Healthcare Cash Flow for Dividends Related Terms

TTK Healthcare Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare Cash Flow for Dividends Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -84.78 -141.30 -141.30 -141.30 -141.30

TTK Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:507747
76GF Score
TTK Healthcare Ltd BOM:507747
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTK Healthcare Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
TTK Healthcare (BOM:507747) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for TTK Healthcare and its competitors.
Is TTK Healthcare's Cash Flow for Dividends too high?
TTK Healthcare's current Cash Flow for Dividends is ₹0 Mil. Overall, TTK Healthcare has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Cash Flow for Dividends compare to LLY and JNJ?
TTK Healthcare's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for TTK Healthcare and its competitors. TTK Healthcare's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,453.45, compared to a current price of ₹921.35 — trading 36.6% below its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. TTK Healthcare's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹921.35 is trading 36.6% below its estimated GF Value™ of ₹1,453.45. GuruFocus considers TTK Healthcare to be Significantly Undervalued.

Key valuation signals for BOM:507747:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹1,453.45 vs. price of ₹921.35 (36.6% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
76GF Score

Get the complete analysis for BOM:507747

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹921.35
Price
₹1,453.45
GF Value